Association of FAS, a TNF-α receptor gene, with treatment resistant schizophrenia

Schizophrenia Research

Volumn 129, Issue 2-3, 2011, Pages 211-212

  Jia, Peilin ^a   Jayathilake, Karu ^a   Zhao, Zhongming ^a   Meltzer, Herbert Y ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ALLELE; CONTROLLED STUDY; FAS GENE; GENE; GENETIC ASSOCIATION; GENETIC DISTANCE; GENOTYPE; HAPLOTYPE; HUMAN; LETTER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESISTANT SCHIZOPHRENIA;

ANTIGENS, CD95; ANTIPSYCHOTIC AGENTS; DRUG RESISTANCE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA;

EID: 79957990864     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2011.04.013     Document Type: Letter

References (10)

1. Altamura A.C., Boin F., Maes M. HPA axis and cytokines dysregulation in schizophrenia: potential implications for the antipsychotic treatment. Eur. Neuropsychopharmacol. 1999, 10(1):1-4.
2. Calopa M., Bas J., Callen A., Mestre M. Apoptosis of peripheral blood lymphocytes in Parkinson patients. Neurobiol. Dis. 2010, 38(1):1-7.
3. Glantz L.A., Gilmore J.H., Lieberman J.A., Jarskog L.F. Apoptotic mechanisms and the synaptic pathology of schizophrenia. Schizophr. Res. 2006, 81(1):47-63.
4. Kane J., Honigfeld G., Singer J., Meltzer H. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch. Gen. Psychiatry 1988, 45(9):789-796.
5. Lambert C., Landau A.M., Desbarats J. Fas-beyond death: a regenerative role for Fas in the nervous system. Apoptosis 2003, 8(6):551-562.
6. Maes M., Bocchio Chiavetto L., Bignotti S., Battisa Tura G.J., Pioli R., Boin F., Kenis G., Bosmans E., de Jongh R., Altamura C.A. Increased serum interleukin-8 and interleukin-10 in schizophrenic patients resistant to treatment with neuroleptics and the stimulatory effects of clozapine on serum leukemia inhibitory factor receptor. Schizophr Res 2002, 54(3):281-291.
7. Meltzer H.Y. Treatment of the neuroleptic-nonresponsive schizophrenic patient. Schizophr. Bull. 1992, 18(3):515-542.
8. Need A.C., Ge D., Weale M.E., Maia J., Feng S., Heinzen E.L., Shianna K.V., Yoon W., Kasperaviciute D., Gennarelli M., Strittmatter W.J., Bonvicini C., Rossi G., Jayathilake K., Cola P.A., McEvoy J.P., Keefe R.S., Fisher E.M., St Jean P.L., Giegling I., Hartmann A.M., Moller H.J., Ruppert A., Fraser G., Crombie C., Middleton L.T., St Clair D., Roses A.D., Muglia P., Francks C., Rujescu D., Meltzer H.Y., Goldstein D.B. A genome-wide investigation of SNPs and CNVs in schizophrenia. PLoS Genet. 2009, 5(2):e1000373.
9. Sugino H., Futamura T., Mitsumoto Y., Maeda K., Marunaka Y. Atypical antipsychotics suppress production of proinflammatory cytokines and up-regulate interleukin-10 in lipopolysaccharide-treated mice. Prog. Neuropsychopharmacol. Biol. Psychiatry 2009, 33(2):303-307.
10. Zai G., Muller D.J., Volavka J., Czobor P., Lieberman J.A., Meltzer H.Y., Kennedy J.L. Family and case-control association study of the tumor necrosis factor-alpha (TNF-alpha) gene with schizophrenia and response to antipsychotic medication. Psychopharmacology (Berl) 2006, 188(2):171-182.